about
Hormone Receptors in Serous Ovarian Carcinoma: Prognosis, Pathogenesis, and Treatment ConsiderationsHormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium studyThe role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozoleMicroarray-based oncogenic pathway profiling in advanced serous papillary ovarian carcinoma.Cholesterol depletion by methyl-β-cyclodextrin augments tamoxifen induced cell death by enhancing its uptake in melanoma.Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival.The G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patients.Cytokeratin 5-Positive Cells Represent a Therapy Resistant subpopulation in Epithelial Ovarian Cancer.Hormone response in ovarian cancer: time to reconsider as a clinical target?S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours: Short version 1.0 - AWMF registration number: 032/035OL, June 2013.Association of Hormone Receptor Expression with Survival in Ovarian Endometrioid Carcinoma: Biological Validation and Clinical Implications.Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist).Endocrine therapy in epithelial ovarian cancer.
P2860
Q26751021-5928057F-02F0-4C14-954C-25C922953EAAQ33551425-8F72F695-C593-42A3-86D9-7D0E7A85A813Q33861668-ED6E5D87-CAB5-423E-BEB7-841A369288BFQ33974923-227F9C8D-4502-47D3-9333-8C2B629C05FFQ34246496-ADDDA7B5-6C65-4AD6-B5D1-A069DBA77691Q34486859-CE36192A-C0DE-4518-B01A-F1AB24E8D119Q34950615-0D4ED4B6-909B-4149-916F-4508274AA29DQ36255200-513D2AF2-1F51-4AF8-86D8-E75567DB53FAQ36966197-A0201744-5CC9-4B4B-9859-0F0FD6E1B8FEQ37383301-21F03458-F3C6-48E3-BF9A-ECEB70F85966Q37729055-B0BF281B-A0C6-4958-BC04-4568B504218BQ39001743-0AC4047F-AA8E-42FC-A9C1-71C9A5868824Q39038223-3CBF262A-7890-474D-9233-A49D0B2D8B53
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Tamoxifen for relapse of ovarian cancer
@ast
Tamoxifen for relapse of ovarian cancer
@en
Tamoxifen for relapse of ovarian cancer
@en-gb
Tamoxifen for relapse of ovarian cancer
@nl
type
label
Tamoxifen for relapse of ovarian cancer
@ast
Tamoxifen for relapse of ovarian cancer
@en
Tamoxifen for relapse of ovarian cancer
@en-gb
Tamoxifen for relapse of ovarian cancer
@nl
prefLabel
Tamoxifen for relapse of ovarian cancer
@ast
Tamoxifen for relapse of ovarian cancer
@en
Tamoxifen for relapse of ovarian cancer
@en-gb
Tamoxifen for relapse of ovarian cancer
@nl
P2093
P2860
P3181
P1476
Tamoxifen for relapse of ovarian cancer
@en
P2093
Andrew Bryant
Chris Williams
Iveta Simera
P2860
P304
P3181
P356
10.1002/14651858.CD001034.PUB2
P407
P577
2010-01-01T00:00:00Z